Back to Market返回行情

CNMD CONMED Corporation

USHealthcare
$38.48+4.88%ClosedMarket Cap: $1.16B

As of 2026-07-10 16:00

Why CNMD matters now

CONMED Corporation (CNMD) is a US stock in Healthcare. The latest InvestLog snapshot shows $38.48 with +4.88% on the session and $1.16B in market capitalization; recent performance reads 1-month -9.95% and YTD -19.75%.

The latest financial table shown here is Q1 2026, with revenue of $317.0M, net income of $13.8M, and EPS of $0.45. Investors can compare that operating picture with valuation signals such as P/E 24.07 and FCF yield 12.6%.

The latest indexable market news headline is "CONMED Corporation to Report Second Quarter 2026 Financial Results on July 29, 2026" from Business Wire.

Additional event context on this page matters because analyst consensus is Hold with a median target of $78.00; recent insider activity includes Lockwood Kimberly filing . These signals are research inputs, not a recommendation.

Valuation

P/E (TTM)

24.07

PEG

P/B

0.98

P/S

0.71

EV/EBITDA

10.65

DCF Value

$131.79

FCF Yield

12.6%

Div Yield

1.2%

Margins & Returns

Gross Margin

53.6%

Operating Margin

11.2%

Net Margin

4.0%

ROE

5.4%

ROA

2.4%

ROIC

5.1%

Financials

PeriodRevenueNet IncomeEPS
Q1 2026$317.0M$13.8M$0.45
Q4 2025$373.5M$16.7M$0.54
FY 2025$1.37B$47.1M$1.51
Q3 2025$338.6M$2.9M$0.09

Analyst Ratings

Consensus

Hold

Target (Consensus)

$78.00

Target (Median)

$78.00

Target Range

$61.00 - $95.00

Strong Buy: 0Buy: 0Hold: 6Sell: 0Strong Sell: 0
B of A SecuritiesNeutral
2026-05-18
Wells FargoEqual Weight
2026-05-01
JP MorganNeutral
2026-04-30
Piper SandlerNeutral
2026-03-17
NeedhamHold
2026-01-29

Trading Activity

Insider Trades

Lockwood Kimberlyofficer: Interim Corp Controller & PFO
Sell2026-06-03
Lockwood Kimberlyofficer: Interim Corp Controller & PFO
Sell2026-06-03
Lockwood Kimberlyofficer: Interim Corp Controller & PFO
Sell2026-06-03
Lockwood Kimberlyofficer: Interim Corp Controller & PFO
Sell2026-06-03
Lockwood Kimberlyofficer: Interim Corp Controller & PFO
Sell2026-06-03

Company Info

Sector

Healthcare

Industry

Medical - Devices

Country

US

Exchange

Beta

0.92

CONMED Corporation functions as a medical technology enterprise, specializing in the global development, production, and distribution of surgical instruments and related apparatus for a variety of surgical procedures. Its comprehensive product portfolio includes specialized orthopedic surgical items, such as the TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-Knot All-Suture Anchors, and PopLok Knotless Suture Anchors. These innovative offerings provide unique clinical advantages to orthopedic surgeons for repairing soft tissue injuries and are complemented by supportive tools that facilitate minimally invasive sports medicine operations. These orthopedic solutions are marketed under prominent brand names, including Hall, CONMED Linvatec, Concept, and Shutt. Furthermore, CONMED supplies general surgical equipment, encompassing items for clinical insufflation, smoke evacuation, electrosurgical interventions, and endomechanical applications. Its endoscopic technology segment provides both diagnostic and therapeutic instruments utilized in gastroenterological procedures, alongside products specifically designed for addressing conditions of the biliary system. The company also offers cardiac monitoring solutions, featuring ECG and EEG electrodes, and pads for cardiac defibrillation. CONMED distributes its diverse range of products directly to a wide array of healthcare facilities, including hospitals and surgical centers, and also leverages specialized medical distributors. Established in 1970, CONMED Corporation maintains its corporate headquarters in Largo, Florida.